MAPT and dementia: Meanwhile, there is an urgent need to develop diagnostic tools for early dementia of DS because disease-modifying therapies under development for AD, aiming at the reduction of Aβ and/or tau aggregation, could also be effective for the prevention of dementia in DS patients.